共 42 条
- [41] Pretreatment Fibrinogen-Albumin Ratio (FAR) Associated with Treatment Response and Survival in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Anti-PD-1 Therapy Plus Platinum-Based Combination Chemotherapy CANCER MANAGEMENT AND RESEARCH, 2022, 14 : 377 - 386
- [42] First-line-Therapie beim inoperablen oder metastasierten MelanomRandomisierte, offene, multizentrische Phase-I/II-Studie zur Sicherheit und Wirksamkeit einer Triple-Therapie mit dem BRAF-Inhibitor Encorafenib und dem MEK-Inhibitor Binimetinib in Kombination mit dem Anti-PD-1-Antikörper Pembrolizumab bei Patienten mit BRAF-mutiertem MelanomFirst-line therapy for inoperable or metastatic melanomaRandomized, open, multicenter phase I/II study on the safety and efficacy of triple therapy with the BRAF inhibitor encorafenib and the MEK inhibitor binimetinib in combination with the anti-PD-1 antibody pembrolizumab in patients with BRAF-mutated melanoma Forum, 2020, 35 (2) : 146 - 147